Stockreport

Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Gyre Therapeutics, Inc.  (GYRE) 
PDF Gyre Therapeutics Inc. Full-year 2025 revenue increased 10% year-over-year to $116.6 million, within revised guidance range Full year 2026 revenue guidance of $100. [Read more]